Payment overview · 2025
General Payments
$299.98
2 reported records · 1 companies
Healthcare provider profile · identity verified
Nael A Abutabikh, MD
Allopathic & Osteopathic Physicians|Internal Medicine · LIVINGSTON, NJ · NPI 1235120155
Verified facts
What the public records show
CMS Open Payments records show Nael A Abutabikh, MD received $299.98 in general payments during 2025 across 2 reported records.
Madrigal Pharmaceuticals accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Madrigal Pharmaceuticals | Unresolved — no canonical attribution shown | $299.98 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $299.98 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REZDIFFRA Normalized: rezdiffra |
Drug | Madrigal Pharmaceuticals | $299.98 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 755 | 197 |
| Amlodipine Besylate | Amlodipine Besylate | 522 | 131 |
| Metformin Hcl | Metformin Hcl | 264 | 91 |
| Pantoprazole Sodium | Pantoprazole Sodium | 253 | 63 |
| Tamsulosin Hcl | Tamsulosin Hcl | 247 | 57 |
| Gabapentin | Gabapentin | 246 | 61 |
| Omeprazole | Omeprazole | 240 | 93 |
| Naproxen | Naproxen | 239 | 132 |
| Levothyroxine Sodium | Levothyroxine Sodium | 231 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 202 | 59 |
| Lisinopril | Lisinopril | 201 | 47 |
| Eliquis | Apixaban | 198 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 174 | 70 |
| Losartan Potassium | Losartan Potassium | 168 | 44 |
| Diclofenac Sodium | Diclofenac Sodium | 167 | 103 |
| Donepezil Hcl | Donepezil Hcl | 150 | 32 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 145 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 144 | 38 |
| Furosemide | Furosemide | 141 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 131 | 80 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 130 | 15 |
| Ibuprofen | Ibuprofen | 128 | 84 |
| Vascepa | Icosapent Ethyl | 124 | 32 |
| Carvedilol | Carvedilol | 121 | 26 |
| Mirtazapine | Mirtazapine | 117 | 23 |
| Warfarin Sodium | Warfarin Sodium | 116 | suppressed |
| Jardiance | Empagliflozin | 114 | 17 |
| Simvastatin | Simvastatin | 114 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 113 | 33 |
| Enalapril Maleate | Enalapril Maleate | 112 | 24 |
| Trazodone Hcl | Trazodone Hcl | 107 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 106 | 36 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 103 | 33 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 100 | 66 |
| Hydralazine Hcl | Hydralazine Hcl | 99 | 18 |
| Ozempic | Semaglutide | 98 | 17 |
| Azithromycin | Azithromycin | 96 | 71 |
| Alendronate Sodium | Alendronate Sodium | 95 | 21 |
| Montelukast Sodium | Montelukast Sodium | 93 | 31 |
| Finasteride | Finasteride | 87 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 86 | 15 |
| Divalproex Sodium | Divalproex Sodium | 85 | 17 |
| Memantine Hcl | Memantine Hcl | 85 | 11 |
| Januvia | Sitagliptin Phosphate | 76 | 16 |
| Glimepiride | Glimepiride | 75 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 72 | 21 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 71 | 16 |
| Albuterol Sulfate | Albuterol Sulfate | 69 | suppressed |
| Methylprednisolone | Methylprednisolone | 69 | 47 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 56 | 35 |
| Levetiracetam | Levetiracetam | 55 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 55 | 11 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 54 | suppressed |
| Entresto | Sacubitril/Valsartan | 53 | suppressed |
| Xarelto | Rivaroxaban | 53 | suppressed |
| Prednisone | Prednisone | 52 | 13 |
| Icosapent Ethyl | Icosapent Ethyl | 51 | 20 |
| Meclizine Hcl | Meclizine Hcl | 51 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 50 | 43 |
| Novolog Flexpen | Insulin Aspart | 48 | suppressed |
| Sucralfate | Sucralfate | 48 | 19 |
| Farxiga | Dapagliflozin Propanediol | 47 | suppressed |
| Hydrocortisone | Hydrocortisone | 46 | 38 |
| Clonidine Hcl | Clonidine Hcl | 45 | suppressed |
| Spironolactone | Spironolactone | 45 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 44 | 13 |
| Alprazolam | Alprazolam | 42 | 11 |
| Buspirone Hcl | Buspirone Hcl | 42 | suppressed |
| Insulin Lispro | Insulin Lispro | 42 | 11 |
| Mometasone Furoate | Mometasone Furoate | 41 | 22 |
| Amoxicillin | Amoxicillin | 40 | 33 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 40 | 11 |
| Ezetimibe | Ezetimibe | 39 | 12 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 39 | suppressed |
| Nystatin | Nystatin | 39 | 23 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 39 | 31 |
| Alogliptin | Alogliptin Benzoate | 38 | suppressed |
| Meloxicam | Meloxicam | 38 | 21 |
| Lactulose | Lactulose | 37 | 19 |
| Dexlansoprazole Dr | Dexlansoprazole | 36 | suppressed |
| Glipizide | Glipizide | 36 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 35 | 11 |
| Jantoven | Warfarin Sodium | 33 | suppressed |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 33 | 22 |
| Ondansetron Hcl | Ondansetron Hcl | 33 | 27 |
| Baclofen | Baclofen | 32 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Ketoconazole | Ketoconazole | 32 | 15 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 32 | 19 |
| Acetylcysteine | Acetylcysteine | 31 | suppressed |
| Latanoprost | Latanoprost | 31 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 31 | 11 |
| Lansoprazole | Lansoprazole | 30 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 29 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 29 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 29 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 29 | suppressed |
| Budesonide | Budesonide | 28 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 28 | suppressed |
| Allopurinol | Allopurinol | 26 | suppressed |
| Bumetanide | Bumetanide | 26 | suppressed |
| Levofloxacin | Levofloxacin | 26 | 22 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | 11 |
| Gemfibrozil | Gemfibrozil | 25 | suppressed |
| Lacosamide | Lacosamide | 25 | suppressed |
| Lidocaine | Lidocaine | 25 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 25 | 18 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 24 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 24 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 24 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 23 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 23 | 11 |
| Tramadol Hcl | Tramadol Hcl | 23 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Hydrocortisone Butyrate | Hydrocortisone Butyrate | 22 | 12 |
| Labetalol Hcl | Labetalol Hcl | 22 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 22 | 18 |
| Enoxaparin Sodium | Enoxaparin Sodium | 21 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 21 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 20 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 19 | 11 |
| Linzess | Linaclotide | 19 | suppressed |
| Mupirocin | Mupirocin | 19 | 18 |
| Tradjenta | Linagliptin | 19 | suppressed |
| Metronidazole | Metronidazole | 18 | 14 |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Risperidone | Risperidone | 18 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 17 | 12 |
| Desloratadine | Desloratadine | 17 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 17 | suppressed |
| Famotidine | Famotidine | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Miconazole-Zinc Oxide-Petroltm | Miconazole Nitrate/Zinc Ox/Pet | 17 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Easy Comfort Pen Needles | Pen Needle, Diabetic | 16 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 16 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 16 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Potassium Chloride | Potassium Chloride | 16 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 16 | 13 |
| Sps | Sodium Polystyrene Sulfon/Sorb | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Clonazepam | Clonazepam | 15 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 15 | suppressed |
| Loperamide | Loperamide Hcl | 15 | 13 |
| Valsartan | Valsartan | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | 11 |
| Glipizide Er | Glipizide | 14 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 14 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Clarithromycin | Clarithromycin | 12 | suppressed |
| Clobazam | Clobazam | 12 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Juluca | Dolutegravir/Rilpivirine | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Lorazepam | Lorazepam | 11 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $299.98 · 2 records | Madrigal Pharmaceuticals | REZDIFFRA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error